Literature DB >> 26494513

Functional interaction between OX2 and CB1 receptors in the ventral tegmental area and the nucleus accumbens in response to place preference induced by chemical stimulation of the lateral hypothalamus.

Fatemeh Yazdi1, Mahboubeh Jahangirvand2, Amir-Hossein Pirasteh3, Marzieh Moradi4, Abbas Haghparast5.   

Abstract

Orexinergic projections derived from the lateral hypothalamus (LH) to the ventral tegmental area (VTA) and the nucleus accumbens (NAc), play a key role in the acquisition of conditioned place preference (CPP) induced by LH stimulation. On the other hand, there are several studies which support the idea of the existence of a cross-talk between the orexinergic and cannabinoid systems. Nevertheless, the function and how both systems interact in the reward circuit remain unknown. In this study, the authors tried to clarify the role of orexin-2 receptor (OX2r) within the VTA and NAc in the development of reward-related behaviors after chemical stimulation of the LH and also find out the involvement of CB1 cannabinoid receptors in this phenomenon. Animals were implanted by two separate cannulae into the LH and VTA or NAc, unilaterally. The CPP paradigm was done; and conditioning scores were recorded. The results showed that administration of TCS OX2 29 as a selective OX2r antagonist (1, 3 and 10 nM/rat) into the VTA or NAc just 5 min before microinjection of carbachol (250 nM/0.5 μl saline), a cholinergic agonist, into the LH during the 3-day conditioning phase, could dose-dependently inhibit the development of LH stimulation-induced CPP. Furthermore, concurrent injection of ineffective doses of TCS OX2 29 and AM251, as a CB1 receptor antagonist, into the NAc could reduce conditioning scores. The findings of this study showed that the OX2 receptor has a critical role in modulating reward circuit in the VTA and NAc, when the LH was stimulated by carbachol. Moreover, we suggest the existence of an interaction between orexinergic and cannabinoid systems within the VTA and NAc in place preference induced by LH stimulation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cannabinoid receptors; Lateral hypothalamus; Nucleus accumbens; Orexin receptors; Reward; Ventral tegmental area

Mesh:

Substances:

Year:  2015        PMID: 26494513     DOI: 10.1016/j.pbb.2015.10.012

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Mutual assistance of nucleus accumbens cannabinoid receptor-1 and orexin receptor-2 in response to nicotine: a single-unit study.

Authors:  Reza Fartootzadeh; Hojjatallah Alaei; Parham Reisi
Journal:  Res Pharm Sci       Date:  2021-03-05

2.  In vivo Evidence for Brain Region-Specific Molecular Interactions Between Cannabinoid and Orexin Receptors.

Authors:  Hye Ji J Kim; Ayat Zagzoog; Anna Maria Smolyakova; Udoka C Ezeaka; Michael J Benko; Teagan Holt; Robert B Laprairie
Journal:  Front Neurosci       Date:  2021-12-21       Impact factor: 4.677

Review 3.  Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone.

Authors:  Martin A Katzman; Matthew P Katzman
Journal:  Brain Sci       Date:  2022-01-24

Review 4.  Hedonic Eating and the "Delicious Circle": From Lipid-Derived Mediators to Brain Dopamine and Back.

Authors:  Roberto Coccurello; Mauro Maccarrone
Journal:  Front Neurosci       Date:  2018-04-24       Impact factor: 4.677

5.  Overlapping Distribution of Orexin and Endocannabinoid Receptors and Their Functional Interaction in the Brain of Adult Zebrafish.

Authors:  Roberta Imperatore; Livia D'Angelo; Omid Safari; Hamidreza Ahmadniaye Motlagh; Fabiana Piscitelli; Paolo de Girolamo; Luigia Cristino; Ettore Varricchio; Vincenzo di Marzo; Marina Paolucci
Journal:  Front Neuroanat       Date:  2018-07-30       Impact factor: 3.856

6.  The effect of intracerebroventricular administration of orexin receptor type 2 antagonist on pentylenetetrazol-induced kindled seizures and anxiety in rats.

Authors:  Saeedeh Asadi; Ali Roohbakhsh; Ali Shamsizadeh; Masoud Fereidoni; Elham Kordijaz; Ali Moghimi
Journal:  BMC Neurosci       Date:  2018-08-13       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.